| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $8.3M | +2077.6% | -8.7% |
| Cost of Revenue | $989K | -50.8% | -25.3% |
| R&D Expense | $1.3M | -14.6% | -4.0% |
| SG&A Expense | $2.6M | -10.5% | -3.9% |
| Operating Income | -$2.0M | -162.9% | -16.0% |
| Interest Expense | $110K | +0.1% | -20.1% |
| Pre-tax Income | -$1.9M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $15.2M | -5.5% | -13.0% |
| Accounts Receivable | $10.4M | +1.1% | -7.8% |
| Inventory | $2.9M | -8.9% | -34.9% |
| Current Assets | $29.9M | -4.1% | -15.0% |
| Total Assets | $65.9M | -3.0% | -14.1% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $4.9M | — | — |
| Capital Expenditures | $98K | — | — |
| Investing Cash Flow | -$1.6M | — | — |
| Financing Cash Flow | -$6.1M | — | — |
| Free Cash Flow | $4.8M | — | — |
| -166.4% |
| -27.4% |
| Income Tax | $6K | -0.0% | -50.4% |
| Net Income | -$1.9M | -162.0% | -25.7% |
| EPS (Basic) | -$0.13 | -160.0% | -18.2% |
| EPS (Diluted) | -$0.13 | -160.0% | -18.2% |
| $24.3M |
| +1.4% |
| -21.8% |
| Total Liabilities | $40.1M | -0.3% | -23.3% |
| Stockholders' Equity | $26.1M | -6.7% | +5.4% |